Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study

Objectives –  Baseline brain single‐photon emission computed tomography (SPECT) can predict mild cognitive impairment (MCI) patients at risk for progressive MCI (PMCI).

[1]  J. Hatazawa,et al.  Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[3]  P Gerundini,et al.  Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  R Kawashima,et al.  Retention of words in long‐term memory: a functional neuroanatomical study with PET , 2000, Neuroreport.

[5]  Kazunari Ishii,et al.  Relatively Preserved Hippocampal Glucose Metabolism in Mild Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[6]  R. Mohs,et al.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease , 1998, Neurology.

[7]  A. Convit,et al.  Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.

[8]  R. Koeppe,et al.  Anatomic standardization: linear scaling and nonlinear warping of functional brain images. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  O Almkvist,et al.  Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment , 2001, Neuroreport.

[10]  S. Ferris,et al.  Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .

[11]  G Mariani,et al.  99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  W. Scoville,et al.  LOSS OF RECENT MEMORY AFTER BILATERAL HIPPOCAMPAL LESIONS , 1957, Journal of neurology, neurosurgery, and psychiatry.

[13]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[14]  A. Alavi,et al.  The role of PET imaging in the management of patients with central nervous system disorders. , 2005, Radiologic clinics of North America.

[15]  Tetsuya Mori,et al.  Detectability of hypometabolic regions in mild Alzheimer disease: function of time after the injection of 2-[fluorine 18]-fluoro-2-deoxy-D-glucose. , 2005, AJNR. American journal of neuroradiology.

[16]  W E Wilkinson,et al.  Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test. , 1987, Archives of neurology.

[17]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[18]  L. Squire,et al.  Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  Paolo Vitali,et al.  Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease , 2005, Clinical Neurophysiology.

[20]  Ivo D Dinov,et al.  Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. , 2005, Archives of neurology.

[21]  R. Koeppe,et al.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[23]  K. Ishii,et al.  Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[25]  J. Touchon,et al.  A Typology of Sub-Clinical Senescent Cognitive Disorder , 1996, British Journal of Psychiatry.

[26]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[27]  M. Angermeyer,et al.  Mild cognitive impairment 1 – a review of prevalence, incidence and outcome according to current approaches , 2002, Acta psychiatrica Scandinavica.

[28]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[29]  Lars-Olof Wahlund,et al.  Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment , 2002, BMC neurology.

[30]  J Philip Miller,et al.  Rates of progression in mild cognitive impairment and early Alzheimer’s disease , 2002, Neurology.